Monday, February 6, 2006

Exenatide (Byetta) Reviewed by Clinical Cases and Images

From Clinical Cases and Images:
Glucagon-like peptide-1 (GLP-1) is a GI peptide that stimulates glucose-dependent insulin secretion (similar to sulfonylureas). GLP-1 also inhibits glucagon release, gastric emptying and food absorption.
Technorati Tags: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)